Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00894231 · ClinicalTrials.gov registry record · Phase 4
Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis
A Phase 4 study of Perennial Allergic Rhinitis, sponsored by AAADRS Clinical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT00894231 is a Phase 4 study of Perennial Allergic Rhinitis that has completed, run by AAADRS Clinical Research Center. The registered enrollment target is 30 participants, below the 603-participant average among 4 other Perennial Allergic Rhinitis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00894231, a Phase 4 study of Perennial Allergic Rhinitis, has completed, sponsored by AAADRS Clinical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.
Conditions Studied
Interventions
- DRUG placebo
- DRUG levocetirizine (Xyzal)
Study Locations (1)
Florida
- AAADRS - Coral Gables
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00894231
The ClinicalTrials.gov registry entry for NCT00894231 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 603-participant average among 4 other Perennial Allergic Rhinitis trials with a reported enrollment target (95% lower). The listed sponsor is AAADRS Clinical Research Center, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Perennial Allergic Rhinitis appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.
NCT00894231 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00894231 about?
NCT00894231 is a clinical study titled "Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis". The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.
What is the current status of trial NCT00894231?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2009-01. Estimated completion is 2009-08.
What conditions does trial NCT00894231 study?
This clinical trial studies the following conditions: Perennial Allergic Rhinitis.
What interventions are being tested in trial NCT00894231?
The interventions under investigation include: placebo (DRUG), levocetirizine (Xyzal) (DRUG).
Who is sponsoring clinical trial NCT00894231?
This trial is sponsored by AAADRS Clinical Research Center, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00894231 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Perennial Allergic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)
COMPLETED · Phase 4
-
Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR)
COMPLETED · Phase 3
-
Safety Study of Olopatadine Nasal Spray
COMPLETED · Phase 3
-
Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.